166 related articles for article (PubMed ID: 1903170)
1. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.
Shin RW; Iwaki T; Kitamoto T; Tateishi J
Lab Invest; 1991 May; 64(5):693-702. PubMed ID: 1903170
[TBL] [Abstract][Full Text] [Related]
2. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
Papasozomenos SC
Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
[TBL] [Abstract][Full Text] [Related]
3. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.
Kowall NW; Kosik KS
Ann Neurol; 1987 Nov; 22(5):639-43. PubMed ID: 3122646
[TBL] [Abstract][Full Text] [Related]
4. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
[TBL] [Abstract][Full Text] [Related]
5. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
6. Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Demonstration using the hydrated autoclaving method.
Shin RW; Iwaki T; Kitamoto T; Sato Y; Tateishi J
Am J Pathol; 1992 Apr; 140(4):937-45. PubMed ID: 1373272
[TBL] [Abstract][Full Text] [Related]
7. Archival, formalin-fixed tissue: its use in the study of Alzheimer's type changes.
Dwork AJ; Liu D; Kaufman MA; Prohovnik I
Clin Neuropathol; 1998; 17(1):45-9. PubMed ID: 9496540
[TBL] [Abstract][Full Text] [Related]
8. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
Joachim CL; Morris JH; Kosik KS; Selkoe DJ
Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease.
Masliah E; Mallory M; Alford M; Hansen LA; Saitoh T
Lab Invest; 1993 Nov; 69(5):562-9. PubMed ID: 8246448
[TBL] [Abstract][Full Text] [Related]
10. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
Shin RW; Ogomori K; Kitamoto T; Tateishi J
Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
12. [Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue].
Parent M; Delacourte A; Défossez A; Hémon B; Han KK; Petit H
C R Acad Sci III; 1988; 306(13):391-7. PubMed ID: 3136867
[TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
14. [A semiquantitative study on Alzheimer neurofibrillary tangles demonstrated immunohistochemically with anti-tau antibodies, in the brains of non-demented and demented old people].
Kuzuhara S; Ihara Y; Toyokura Y; Shimada H
No To Shinkei; 1989 May; 41(5):465-70. PubMed ID: 2508732
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of the microtubule-associated protein, tau, in Alzheimer's disease tissue to formalin fixation.
Pollock NJ; Wood JG
J Histochem Cytochem; 1988 Sep; 36(9):1117-21. PubMed ID: 2841371
[TBL] [Abstract][Full Text] [Related]
17. Microtubular reorganization and dendritic growth response in Alzheimer's disease.
McKee AC; Kowall NW; Kosik KS
Ann Neurol; 1989 Nov; 26(5):652-9. PubMed ID: 2817839
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
Gómez-Ramos P; Mufson EJ; Morán MA
Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149
[TBL] [Abstract][Full Text] [Related]
19. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
20. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
